Skip to content
Login Register

#drug testing

2 public questions tagged with this topic.

Animal Tissue Culture 3

The phase of cell growth most suitable for drug testing is:

Pharmacological testing and chemosensitivity evaluation are most predictive during logarithmic exponential growth phase when cell population is actively cycling, metabolically robust, and homogeneous. During lag, cells are still recovering and fraction in S phase low, causing underestimation of antimetabolite efficacy. In log phase, DNA synthesis enzymes including topoisomerase II, thymidylate synthase, and kinases targeted by many drugs are highly expressed, mitochondrial activity high, ATP levels stable. Dose-response curves generated in this window show reproducible IC50 values. Plateau or quiescent cultures activate stress pathways, upregulate drug efflux transporters such as P-glycoprotein, increase glutathione detoxification, and exhibit reduced incorporation of nucleoside analogs leading to false resistance. For agents specific to S or M phases such as 5-fluorouracil, doxorubicin, paclitaxel, presence of cycling cells is essential. Therefore standard protocols seed cells 24 hours before dosing to allow attachment and entry into log before drug addition, measure viability after 48-72 hours using MTT or ATP luminescence, ensuring correlation with in vivo proliferative tumor tissue sensitivity.

Ref: Freshney Ch.21 Drug testing log phase; NIH Assay Guidance Manual 2021 Chemosensitivity assays log phase optimal viability.

View Details
Animal Tissue Culture 3

The in vitro system closest to in vivo liver toxicity testing is:

Cultured animal cells divide into two fundamental categories with distinct biological properties. Primary cultures derived directly from tissue explants retain finite lifespan, diploid karyotype, anchorage dependence, contact inhibition, and tissue-specific functions such as albumin secretion by hepatocytes, but undergo senescence after limited doublings due to telomere shortening and activation of p53-p16 checkpoints. Continuous or established lines arise via spontaneous or experimentally induced transformation events that inactivate tumor suppressors, activate telomerase hTERT maintaining telomere length, and induce aneuploidy leading to indefinite proliferation, reduced serum dependence, growth in soft agar, and loss of contact inhibition. Understanding this distinction influences experimental design: primary cells offer physiological relevance for toxicology, differentiation, and personalized medicine but limited supply and donor variability, while continuous lines provide unlimited scalable material for genetic manipulation, protein production, and high throughput screening though carrying aberrant signaling requiring authentication via short tandem repeat profiling and mycoplasma testing before publication. Regulatory agencies recommend limiting use of transformed lines for preclinical toxicity extrapolations requiring primary cell validation. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.

Ref: Freshney Ch.15 Primary vs continuous cell lines finite vs infinite; Alberts MBoC Ch.20 Transformation and immortalization characteristics.

View Details